Minimum 20 minute delay
9/18/2014 7:30:52 AMCommitment to delivering innovative medical technologies creates most versatile cordless ultrasonic offering in the industry DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 18, 2014-- Covidien plc (NYSE:COV) today announced the expansion of its Sonicision™ Cordless Ultrasonic Dissection Device portfolio, following …
9/17/2014 4:01:01 PMDUBLIN, Ireland--(BUSINESS WIRE)--Sep. 17, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 13% increase in the quarterly dividend rate, from $0.32 per ordinary share to $0.36 per ordinary share. “This increase is consistent with our Board’s stated objective of moving to a higher payout ratio and…
9/15/2014 7:00:54 AMDUBLIN, Ireland--(BUSINESS WIRE)--Sep. 15, 2014-- Covidien plc announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the company’s advanced neurovascular solutions. …
A Partner in Health
Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.
One look. One Covidien. Experience the new unified look of Covidien. Easy-to-use labeling. New outside packaging with the same quality products inside. First-class service and support.